Bill

Bill > S1712


US S1712

DISARM Act of 2019 Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019


summary

Introduced
06/04/2019
In Committee
06/04/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

A bill to amend title XVIII of the Social Security Act to encourage the development and use of DISARM antimicrobial drugs, and for other purposes. This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.

AI Summary

This bill, the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019, aims to encourage the development and use of antimicrobial drugs that treat serious or life-threatening infections, including those caused by resistant pathogens. It does this by providing additional Medicare payment for services involving certain DISARM-designated antimicrobial drugs, subject to certain requirements for hospitals such as participating in antimicrobial use and resistance reporting programs and having antimicrobial stewardship programs. The bill also requires the Government Accountability Office to study and report on barriers to developing such antimicrobial drugs and recommend ways to address those barriers.

Committee Categories

Budget and Finance

Sponsors (3)

Last Action

Read twice and referred to the Committee on Finance. (on 06/04/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...